# Terrebonne General Health System – FDA Inspection, Feb 10, 2017

Source: https://www.keypedia.com/records/fda_inspections/terrebonne-general-health-system/6e427052-7fa3-4bc9-849e-a42c83b475c5
Source feed: FDA_Inspections

> FDA inspection 1000028 of Terrebonne General Health System, February 10, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1000028
- Company Name: Terrebonne General Health System
- Inspection Date: 2017-02-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1283764 - 2025-09-09
- FDA Inspection 1217492 - 2023-08-24
- FDA Inspection 1102308 - 2019-08-28
- [FDA Inspection 928625 - 2015-06-02](https://www.keypedia.com/records/fda_inspections/terrebonne-general-health-system/8c380f0a-d658-4a78-94fd-e8da41818294)
- FDA Inspection 826416 - 2013-04-04

## Related Officers

- [Company Rep](https://www.keypedia.com/people/barbara-d-wright/c824bcb9-76fb-4e83-86d0-013a9584c137)

Company: https://www.keypedia.com/companies/terrebonne-general-health-system/7b7ea427-a275-42d9-914a-ef84af0f4cd3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d